Grass City 20% OFF

HENDERSON, NV / ACCESSWIRE / November 28, 2018 / Let’s take a look at what several stocks look like before the end of the year.

Today we are highlighting: Real Brands, Inc. (RLBD), OrganiGram Holdings, Inc. (OGRMF), KushCo Holdings, Inc. (OTCQB:KSHB), CV Sciences, Inc. (OTCQB:CVSI), and Aphria, Inc. (NYSE:APHA).

Although cannabis-infused drinks are predicted to be the next big thing, most of the larger beverage companies are still apprehensive about jumping on board.

While every week a new report surfaces about these companies exploring opportunities in the liquid CBD game, the reality is very few have actually taken the plunge.

This is fantastic news for smaller cannabis companies developing CBD beverages; they have time to gain a piece of the market and make themselves an attractive candidate to larger companies when they decide to enter the space.

Take Real Brands, Inc. (RLBD) (Market Cap: $2.254M Share Price: $0.13) for example; the company is developing a CBD beverage brand called Omega Hemp. They recently explained that they are in the final stages of scheduling their first production run of water and they will confirm the timing in the next 60 days. RLBD has strong management with a solid background in branding and the beverage industry and plans to expand their holdings focusing on at least three CBD Categories: smokables, edibles and topical balms and lotions.

Another Canadian cannabis company worth radaring is OrganiGram Holdings, Inc. (OGRMF) (Market Cap: $509.91M Share Price: $4.02), which is a leading licensed producer of cannabis for the medical and adult-use recreational markets.

KushCo Holdings, Inc. (KSHB) (Market Cap: $414.61 Share Price: $5.28) recently reported their 2018 results, the company reported revenue up 177% Year-over-Year to $52.1 million. Gross margins were 24.2%, compared with 35.2% in the prior year period, this is primarily related to the year-end inventory adjustments of $2.8 million. Excluding this year end adjustment, gross margins for the year would have been 30%.

CV Sciences, Inc. (CVSI) (Market Cap: $351.857M Share Price: $3.72) reported Q3/18 earnings on November 7, surpassing expectations. Top line year to year sales growth was over 143%. CVSI operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD and a consumer-product division focused on manufacturing, marketing and selling plant-based CBD products (PlusCBD Oil?) to a range of market sectors.

Aphria, Inc. (APHA) (Market Cap: $2.071B Share Price: $8.19) announced an agreement with Rapid Dose Therapeutics Inc. that grants the company with exclusive global-preferred rights to license, manufacture, distribute and sell RDT’s QuickStrip? innovative, proprietary delivery technology for both medical and adult-use cannabis market. This is the latest addition to the company’s growing portfolio and makes it another stock in the industry to monitor.

Legal Disclaimer:

This article was written by Regal Consulting, LLC (“Regal Consulting”). Regal Consulting has agreed to a three-month term consulting agreement with RLBD dated 8/31/18. The agreement calls for $100,000 note issued to Regal Consulting, and 2,500,000 restricted 144 shares of RLBD for three months of service. Regal has elected to convert $73,000 of principal of the $100,000 note into 2,761,872 Restricted 144 shares of RLBD. All payments were made directly by Real Brands, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. RLBD was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice. legal disclaimer/ Full Legal Disclaimer Click Here.

Contact Information:

Company Name: Microcap Speculators

Contact Person: Media Manager


Phone: 1-702-720-6310

Country: United States


CONTACT: ACR Communication, LLC